Hepatitis C in Young Children: To Treat or Not to Treat – Is It Cost-Effective? - 22/02/21
Doi : 10.1016/j.jpeds.2020.10.032
Norberto Rodriguez-Baez, MD ⁎ 
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX
∗Reprint requests: Norberto Rodriguez-Baez, MD, Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390.Department of PediatricsUniversity of Texas Southwestern Medical Center5323 Harry Hines BlvdDallasTX75390.
Abbreviations : DAA, HCV, QALY
Le texte complet de cet article est disponible en PDF.
| N.R.-B. receives research funding from Gilead. The author declares no conflicts of interest. |
© 2020
Publié par Elsevier Masson SAS.
Vol 230
P. 9-10 - mars 2021 Retour au numéro
Article précédent
- Implementation of a Rapid Evidence Assessment Infrastructure during the Coronavirus Disease 2019 (COVID-19) Pandemic to Develop Policies, Clinical Pathways, Stimulate Academic Research, and Create Educational Opportunities
- Suchitra Rao, Bethany M. Kwan, Donna J. Curtis, Angela Swanson, Leigh Anne Bakel, Lalit Bajaj, Juri Boguniewicz, Justin M. Lockwood, Kaleigh Ogawa, Katherine Pemberton, Robert C. Fuhlbrigge, David Brumbaugh, Patricia Givens, Eva S. Nozik, Marion R. Sills
- “Even When the Wound Is Healed, the Scar Remains”
- Samuel A. Kocoshis
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?